v3.26.1
Acquisitions - Schedule of Fair Value of the Aggregate Consideration Paid or Payable (Details)
$ / shares in Units, $ in Thousands
Jul. 08, 2025
USD ($)
$ / shares
shares
Jul. 07, 2025
shares
Akoya Biosciences, Inc.    
Business Combination [Line Items]    
Exchange Ratio 0.147  
Total shares of Quanterix common stock issued (in shares) | shares 7,517,000  
Quanterix stock price per share as of the closing date (in USD per share) | $ / shares $ 6.54  
Fair value of Akoya common stock and equity instruments converted to Quanterix common stock $ 49,161  
Cash consideration paid 18,942  
Cash paid for debt extinguishment 82,131  
Fair value of replacement equity awards attributable to pre-combination service 739  
Total fair value of consideration transferred $ 150,973  
Fractional shares (in USD per share) | $ / shares $ 0.37  
Business combination, consideration transferred, settlement of early termination, legal, and prepayment fees $ 7,000  
Akoya Biosciences, Inc.    
Business Combination [Line Items]    
Total Akoya common stock and equity instruments outstanding as of July 7, 2025 to be converted (in shares) | shares   51,136,000